NO971196L - Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid - Google Patents

Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid

Info

Publication number
NO971196L
NO971196L NO971196A NO971196A NO971196L NO 971196 L NO971196 L NO 971196L NO 971196 A NO971196 A NO 971196A NO 971196 A NO971196 A NO 971196A NO 971196 L NO971196 L NO 971196L
Authority
NO
Norway
Prior art keywords
androst
phenylprop
aza
carboxamide
trifluoro
Prior art date
Application number
NO971196A
Other languages
English (en)
Other versions
NO971196D0 (no
Inventor
Achille Panzeri
Marcella Nesi
Enrico Di Salle
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO971196L publication Critical patent/NO971196L/no
Publication of NO971196D0 publication Critical patent/NO971196D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Epimerene: (22R)-N-(l,l,l-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5 a-androst-l-en- 17 C-karboksamid og (22S)-N-(l,l,l-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5 a- androst-l-en-17 C-karboksamid, som er nyttige som inhibitorer av testosteron-5 a- reductaseenzym, en fremgangsmåte for deres fremstilling og farmasøytiske preparater inneholdende forbindelsene.
NO971196A 1995-07-21 1997-03-14 Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid NO971196D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001587A IT1275594B1 (it) 1995-07-21 1995-07-21 Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
PCT/EP1996/002830 WO1997004002A1 (en) 1995-07-21 1996-06-28 EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5α-ANDROST-1-ENE-17β-CARBOXAMIDE

Publications (2)

Publication Number Publication Date
NO971196L true NO971196L (no) 1997-03-14
NO971196D0 NO971196D0 (no) 1997-03-14

Family

ID=11372032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971196A NO971196D0 (no) 1995-07-21 1997-03-14 Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid

Country Status (17)

Country Link
EP (1) EP0782582A1 (no)
JP (1) JPH10506411A (no)
KR (1) KR970706298A (no)
CN (1) CN1159195A (no)
AR (1) AR003967A1 (no)
AU (1) AU6418396A (no)
BR (1) BR9606527A (no)
CA (1) CA2199273A1 (no)
EA (1) EA199700045A1 (no)
HU (1) HUP9702465A3 (no)
IL (1) IL120343A0 (no)
IT (1) IT1275594B1 (no)
MX (1) MX9701948A (no)
NO (1) NO971196D0 (no)
PL (1) PL319351A1 (no)
WO (1) WO1997004002A1 (no)
ZA (1) ZA965678B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6137399A (en) * 1998-09-09 2000-03-27 Merck & Co., Inc. Method of determining and reducing the risk of bph-related urologic events
JP2002535274A (ja) * 1999-01-25 2002-10-22 スミスクライン・ビーチャム・コーポレイション 抗アンドロゲン剤および疾病の治療方法
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives

Also Published As

Publication number Publication date
EP0782582A1 (en) 1997-07-09
WO1997004002A1 (en) 1997-02-06
JPH10506411A (ja) 1998-06-23
ITMI951587A0 (it) 1995-07-21
MX9701948A (es) 1997-06-28
IL120343A0 (en) 1997-06-10
CA2199273A1 (en) 1997-02-06
IT1275594B1 (it) 1997-08-06
AR003967A1 (es) 1998-09-30
NO971196D0 (no) 1997-03-14
ZA965678B (en) 1997-01-24
PL319351A1 (en) 1997-08-04
CN1159195A (zh) 1997-09-10
HUP9702465A3 (en) 1998-11-30
ITMI951587A1 (it) 1997-01-21
BR9606527A (pt) 1997-12-23
AU6418396A (en) 1997-02-18
HUP9702465A2 (hu) 1998-05-28
EA199700045A1 (ru) 1997-12-30
KR970706298A (ko) 1997-11-03

Similar Documents

Publication Publication Date Title
ATE255589T1 (de) Kristallin form i von clarithromycin
MY107740A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
NO2005025I1 (no) Krystalinsk ceftiofurfri syre, fremgangsmate for fremstilling av denne, og farmasoytisk preparat
DK0982032T3 (da) Anvendelse af en sulfamatesterholdig sterolforbindelse til fremstilling af et lægemiddel til kontrol af østrogenproduktion
NO20015601L (no) Enzym-instantformuleringer av enzymer for dyrefôr
NO20022558L (no) 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor
TR199901578T2 (xx) Klaritromisin form 0 kristali
NO20003514L (no) Hypolipidemiske benzothiazepin-forbindelser
AU3631197A (en) N-benzylpiperidine and tetrahydropyridine derivatives
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
NO991494L (no) &lt;beta&gt;-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer
NO20002676D0 (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
NO971625L (no) Nye peptider med immunomodulatoriske effekter
NO986049L (no) Matrise metallproteinaseinhibitorer
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
NO982229L (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som anti-inflammatoriske midler
NO971196L (no) Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5&lt;alfa&gt;-androst-1-en-17&lt;beta&gt;-karboksamid
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
IL77051A (en) Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
NZ502537A (en) Androst-1-en-3-one derivatives and pharmaceutical formulations thereof; useful for the treatment of alopecia, female hirsutism, seborrhea, and useful for the prevention of bone metastasis caused by prostatic cancer
HUP0102370A2 (hu) Mumbaisztatin, eljárás előállítására és alkalmazása gyógyszerhatóanyagként
AU1200097A (en) 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them
MY110724A (en) Process for converting loracarbef dihydrate to loracarbef monohydrate